The Valley Desk

Clinical trial reportNature communicationsPublished

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature communications
Published
Subject terms
T-Lymphocytes; Humans; Respiratory Tract Infections; Papillomavirus Infections; Vaccines, DNA; Treatment Outcome; Immunotherapy; Adult; Aged; Middle Aged; Female; Male
PubMed ID
39939590
PubMed Central ID
PMC11821913
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal